LNC
70
-2
KMI
65
-2
HPE
68
-5
UPS
40
2
NWL
57
3
VTR
70
3
VIX
19
-2
FITB
72
2
SPG
53
2
MHK
50
2
SIG
52
2
URBN
54
2
ADT
48
2
RF
63
2
NVDA
57
-2
ZBH
45
3
ETN
61
2
PEG
50
4
HSY
50
5
CSX
50
2
LNC
70
-2
KMI
65
-2
HPE
68
-5
UPS
40
2
NWL
57
3
VTR
70
3
VIX
19
-2
FITB
72
2
SPG
53
2
MHK
50
2
SIG
52
2
URBN
54
2
ADT
48
2
RF
63
2
NVDA
57
-2
ZBH
45
3
ETN
61
2
PEG
50
4
HSY
50
5
CSX
50
2
Financhill
Back

Citius Oncology, Inc. 10K Form

Sell
32

CTOR
Citius Oncology, Inc.

Last Price:
$1.15
Seasonality Move:
-10.35%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CTOR News And Ratings

See the #1 stock for the next 7 days that we like better than CTOR

CTOR Financial Statistics

Sales & Book Value

Annual Sales: $0
Cash Flow: $-5.5M
Price / Cash Flow: 0
Annual Sales: $0.54
Price / Book: 2.16

Profitability

EPS (TTM): -0.33790
Net Income (TTM): $-24.8M
Gross Margin: $0
Return on Equity: -64.23%
Return on Assets: -26.44%

Citius Oncology, Inc. Earnings Forecast

Key Citius Oncology, Inc. Financial Ratios

  • Per Share Earnings over the last 5 years have been positive in 2 years.

Citius Oncology, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: CTOR

Debt

Debt-to-Equity Ratio: 0.08
Current Ratio: 0.56
Quick Ratio: 0.08

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CTOR Technical Analysis vs Fundamental Analysis

Sell
32
Citius Oncology, Inc. (CTOR) is a Sell

Is Citius Oncology, Inc. a Buy or a Sell?